
中东和非洲脑脊液管理市场预测至 2028 年 - COVID-19 影响和按产品(脑脊液分流器和脑脊液引流系统)和最终用户(医院、诊所、门诊手术中心和神经中心)进行的区域分析
No. of Pages: 114 | Report Code: TIPRE00028010 | Category: Life Sciences
No. of Pages: 114 | Report Code: TIPRE00028010 | Category: Life Sciences
市场的增长归因于脑脊液 (CSF) 泄漏发生率的增加和不断增长的CSF 管理产品的开发。然而,与CSF分流相关的风险阻碍了市场的增长。
永无止境的技术发展是CSF管理市场增长不可阻挡的趋势。诊断和治疗失败的风险、有限的控制选择和并发症为产品开发人员提供了各种机会。技术的不断进步引入了“智能分流器”的概念,它可以提供高科技控制、诊断和基于通信的分流器或植入物。预计设计的智能分流器可以根据一种或多种测量条件的反馈来控制脑脊液引流。此外,研究人员预计智能分流器有可能对机械分流器提供复杂的控制——有关分流器故障的数据。进一步有望降低分流阻塞的风险,并最终降低故障风险。
市场上运营的后期开发公司需要实验结果来寻求批准并将智能分流器商业化。主要重点是设计用于通过植入压力传感器在医生办公室无创评估 ICP 的分流器以及在临床环境中对 CSF 流量进行无创评估的分流器。这些按需传感系统将是对现有机械阀门的显着先进的补充。
对更好的处理方法不断增长的需求导致了各种产品的开发,从而在中东和非洲脑脊液管理市场增长。例如,2018 年 7 月,FDA 授予 F. Hoffmann-La Roche Ltd 的 Elecsys ×-Amyloid (1-42) CSF 和 Elecsys Phospho-Tau (181P) CSF 突破性器械称号。该产品用作体外诊断免疫分析,测量患有认知障碍的成人脑脊液中的 γ-淀粉样蛋白 (1-42) 和磷酸化 Tau 浓度。他们接受了阿尔茨海默病 (AD) 和其他痴呆症病因的评估。
COVID-19 大流行正在给中东经济造成动荡。例如,叙利亚、利比亚和也门等国家正遭受暴力冲突,无法实施强有力的公共卫生措施。国内外对商品和产品(特别是原油)的需求突然下降,以及由于劳动力短缺而导致的生产停顿是该地区受到的重大影响。
此外,随着疫情的蔓延,神经病学学会、协会举办的各类会议纷纷推迟或取消。预计 COVID-19 大流行将进一步耗尽发展中国家本已脆弱的神经外科系统的资源。
Strategic insights for Middle East and Africa Cerebrospinal Fluid Management involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 48.08 Million |
Market Size by 2028 | US$ 61.68 Million |
Global CAGR (2021 - 2028) | 3.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East and Africa Cerebrospinal Fluid Management refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Cerebrospinal Fluid Management Market is valued at US$ 48.08 Million in 2021, it is projected to reach US$ 61.68 Million by 2028.
As per our report Middle East and Africa Cerebrospinal Fluid Management Market, the market size is valued at US$ 48.08 Million in 2021, projecting it to reach US$ 61.68 Million by 2028. This translates to a CAGR of approximately 3.6% during the forecast period.
The Middle East and Africa Cerebrospinal Fluid Management Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Cerebrospinal Fluid Management Market report:
The Middle East and Africa Cerebrospinal Fluid Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Cerebrospinal Fluid Management Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Cerebrospinal Fluid Management Market value chain can benefit from the information contained in a comprehensive market report.